Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Parkinsonism Relat Disord. 2020 Feb 11;72:23–30. doi: 10.1016/j.parkreldis.2020.02.001

Table 1.

Demographic and clinical characteristics of PD patients at enrollment

Characteristics Enrolled
(n=344)
Completersa
(N=225)
Non-completersb
(N=119)
Age at enrollment, y 61.3 (9.7) 60.9 (9.6) 61.9 (9.9)
Race (% white) 93.6 95.6 89.9
Sex (% male) 66.3 67.1 64.7
Education, y 15.6 (3.0) 15.5 (2.9) 15.7 (3.1)
Disease duration, mo 6.4 (6.4) 6.6 (6.7) 6.1 (5.8)
Duration since symptom onset, mo 23.4 (21.6) 23.1 (17.4) 24.1 (28.0)
Time from symptom onset to diagnosis, mo 17.0 (20.4) 16.5 (16.2) 18.1 (26.6)
Tremor at diagnosis, (%) 77.0 75.6 79.8
Rigidity at diagnosis, (%) 76.2 78.2 72.3
Bradykinesia at diagnosis, (%) 82.3 83.6 79.8
Postural instability at diagnosis, (%) 7.3 7.6 6.7
Family history of PD, (%) 14.4 13.1 16.8
UPDRS Part III score 20.5 (8.7) 20.3 (8.4) 21.0 (9.4)
Hoehn and Yahr stage, median 2.0 1.0 2.0

Abbreviations: PD = Parkinson disease; UPDRS = Unified Parkinson’s Disease Rating Scale. Data are given as mean (SD) for continuous variables, and percentage (%) for categorical variables.

a

Completers are those among the enrolled cases who completed all four SPECT imaging assessments.

b

Non-completers are those among the enrolled cases who completed fewer than four SPECT imaging assessments.